These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22977550)

  • 1. Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma.
    Ohwada A; Inami K; Onuma E; Matsumoto-Yamazaki M; Atsuta R; Takahashi K
    Exp Ther Med; 2011 Jul; 2(4):619-623. PubMed ID: 22977550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
    Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
    J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma Medication Regimens in Pregnancy: Longitudinal Changes in Asthma Status.
    Rohn MCH; Stevens DR; Kanner J; Nobles C; Chen Z; Grantz KL; Sherman S; Grobman WA; Kumar R; Biggio J; Mendola P
    Am J Perinatol; 2023 Jan; 40(2):172-180. PubMed ID: 33882589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fluticasone propionate/formoterol and fluticasone furoate/vilanterol on adolescents with chronic bronchial obstruction.
    Tanninen TH; Pelkonen AS; Malmberg LP; Mäkelä MJ
    J Allergy Clin Immunol Glob; 2024 Aug; 3(3):100268. PubMed ID: 38826625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.
    Sousa AR; Riley JH; Church A; Zhu CQ; Punekar YS; Fahy WA
    NPJ Prim Care Respir Med; 2016 Jun; 26():16031. PubMed ID: 27334739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Inhaled β
    Amegadzie JE; Gamble JM; Farrell J; Gao Z
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1205-1217. PubMed ID: 35645559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vilanterol and fluticasone furoate for asthma.
    Dwan K; Milan SJ; Bax L; Walters N; Powell C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
    Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
    Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
    Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of long-acting β2-agonists plus inhaled corticosteroids for early reversibility in patients with airway obstruction.
    Ozkaya S; Dirican A; Tuna T
    J Thorac Dis; 2013 Aug; 5(4):461-5. PubMed ID: 23991303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids.
    Elkout H; McLay JS; Simpson CR; Helms PJ
    Arch Dis Child; 2010 Oct; 95(10):817-21. PubMed ID: 20656730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
    Domingo C; Rello J; Sogo A
    Drugs; 2019 Nov; 79(16):1729-1737. PubMed ID: 31584145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Eosinophil Cationic Protein Is a Useful Marker for Assessing the Efficacy of Inhaled Corticosteroid Therapy in Children with Bronchial Asthma.
    Guo CL; Sun XM; Wang XW; Guo Q
    Tohoku J Exp Med; 2017 Aug; 242(4):263-271. PubMed ID: 28781336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
    Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
    Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.